Tag:
EndoStim
Latest Headlines
Latest Headlines
Cancer Dx company Metamark rounds up $22M
Cambridge, MA-based Metamark Genetics has raised $22 million in Series B funding. The cancer diagnostics firm's platform--called Metamark's Prognosis Determinans--allows physicians to identify which
